Medtech Insights

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…

The US market for interventional oncology devices will be driven by uptake of advanced and higher-priced technologies—such as radioembolization—favorable clinical data, expanding populations…

The European interventional oncology device market will see modest growth through 2033, driven by increasing incidence and prevalence rates of cancer, cost-effectiveness of ablation and…

Although the interventional oncology procedure volumes are increasing marginally in Japan, the Japanese interventional oncology device market will decline due to limited adoption of minimally…

The Asia Pacific interventional oncology device market will see strong growth through 2033, driven by large and rapidly expanding patient population, increasing popularity of minimally invasive…

The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive…

The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…

The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and…

The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and…

Despite the short-term challenges posed by the COVID-19 pandemic, the Latin America interventional oncology device market will see moderate growth through 2031 driven by a large and rapidly…

The European interventional oncology device market will see moderate growth through 2032, driven by improved reimbursement, increasing popularity of minimally invasive surgeries, and growing…